Tokyo, Sept. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000055501) titled 'Further analysis of protein absorption after ingesting an enteral diet' on Sept. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Meiji Co., Ltd.
Condition:
Condition - Healthy male adults
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This purpose of this study is further analysis of protein absorption after ingesting an enteral diet (UMIN00049118), to compare the amino acids metabolites .
Basic objectives2 - Others
Eligibility:
Age-lower limit - 20
years-old
Gender - Male
Key inclusion criteria - Subjects who joined post study (UMIN00049118) and give informed consent to participate in this further analysis.
Key exclusion criteria - No setting
Target Size - 16
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2024 Year 08 Month 19 Day
Date of IRB - 2024 Year 08 Month 16 Day
Anticipated trial start date - 2024 Year 09 Month 20 Day
Last follow-up date - 2024 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063416
Disclaimer: Curated by HT Syndication.
